Correction to: Comparative Effectiveness, Time to Discontinuation, and Patient-Reported Outcomes with Baricitinib in Rheumatoid Arthritis: 2-Year Data from the Multinational, Prospective Observational RA-BE-REAL Study in European Patients.
Saved in:
| Title: | Correction to: Comparative Effectiveness, Time to Discontinuation, and Patient-Reported Outcomes with Baricitinib in Rheumatoid Arthritis: 2-Year Data from the Multinational, Prospective Observational RA-BE-REAL Study in European Patients. |
|---|---|
| Authors: | Alten, Rieke1 (AUTHOR) rieke.alten@schlosspark-klinik.de, Burmester, Gerd R.2 (AUTHOR), Matucci-Cerinic, Marco3 (AUTHOR), Salmon, Jean-Hugues4 (AUTHOR), Östör, Andrew5,6 (AUTHOR), Ng, Khai Jing7 (AUTHOR), Gerwien, Jens7 (AUTHOR), Zaremba-Pechmann, Liliana8 (AUTHOR), Brnabic, Alan J. M.7 (AUTHOR), Fautrel, Bruno9,10 (AUTHOR) |
| Source: | Rheumatology & Therapy. Feb2026, Vol. 13 Issue 1, p293-297. 5p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 21986576 |
|---|---|
| DOI: | 10.1007/s40744-025-00799-x |
